News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Iframe sync Post navigation Previous: Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext: Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories Brain Clinical Trial Healthcare News Nursing Nutrition Pharmaceutical What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives Staff December 21, 2025 Cancer Diagnostics DNA EHR Healthcare News Vaccine The 3D-Flow Architecture Breakthrough: A Universal, Scalable Digital Processor for Real-Time Pattern Recognition in High-Rate Data Streams — A Platform to Save Millions of Lives and Billions of Euros Staff December 21, 2025 Clinical Trial Healthcare News Patient Care Pharmaceutical After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus? Staff December 20, 2025
